Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation.

Hu Q, Friedrich AM, Johnson LV, Clegg DO.

Stem Cells. 2010 Nov;28(11):1981-91. doi: 10.1002/stem.531.

2.

Stem cell biology and cell transplantation therapy in the retina.

Osakada F, Hirami Y, Takahashi M.

Biotechnol Genet Eng Rev. 2010;26:297-334. Review.

PMID:
21415886
3.

Induced pluripotent stem cells: a new technology to study human diseases.

Vitale AM, Wolvetang E, Mackay-Sim A.

Int J Biochem Cell Biol. 2011 Jun;43(6):843-6. doi: 10.1016/j.biocel.2011.03.013. Epub 2011 Mar 31. Review.

PMID:
21458591
4.

Induced pluripotent stem cells: current progress and potential for regenerative medicine.

Amabile G, Meissner A.

Trends Mol Med. 2009 Feb;15(2):59-68. doi: 10.1016/j.molmed.2008.12.003. Epub 2009 Jan 21. Review.

PMID:
19162546
5.

[Regeneration of the central nervous system using iPS cell-technologies].

Okano H.

Rinsho Shinkeigaku. 2009 Nov;49(11):825-6. Review. Japanese.

PMID:
20030221
6.

[Present status on studies of differentiation into retinal neurons and pigmented cell from induced pluripotent stem cells].

Meng FX, Guo WY.

Zhonghua Yan Ke Za Zhi. 2010 Dec;46(12):1139-42. Review. Chinese.

PMID:
21211229
7.

A transcriptional roadmap to the induction of pluripotency in somatic cells.

Wang Y, Mah N, Prigione A, Wolfrum K, Andrade-Navarro MA, Adjaye J.

Stem Cell Rev. 2010 Jun;6(2):282-96. doi: 10.1007/s12015-010-9137-2. Review.

PMID:
20336394
8.

[Retinal regeneration with iPS cells ‒ Clinical trials for retinal degenerative disorders].

Sugita S.

Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(2):79-85. doi: 10.2177/jsci.38.79. Review. Japanese.

9.

Personalized Medicine: Cell and Gene Therapy Based on Patient-Specific iPSC-Derived Retinal Pigment Epithelium Cells.

Li Y, Chan L, Nguyen HV, Tsang SH.

Adv Exp Med Biol. 2016;854:549-55. doi: 10.1007/978-3-319-17121-0_73. Review.

PMID:
26427458
10.

Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).

Spinelli V, Guillot PV, De Coppi P.

Organogenesis. 2013 Apr-Jun;9(2):101-10. doi: 10.4161/org.25197. Epub 2013 Apr 1. Review.

11.

Pluripotency of induced pluripotent stem cells.

Feng C, Jia YD, Zhao XY.

Genomics Proteomics Bioinformatics. 2013 Oct;11(5):299-303. doi: 10.1016/j.gpb.2013.08.003. Epub 2013 Oct 5. Review.

12.

Human pluripotent stem cell-derived retinal pigmented epithelium in retinal treatment: from bench to bedside.

Parvini M, Satarian L, Parivar K, Javan M, Tondar M, Ahmad S, Baharvand H.

Mol Neurobiol. 2014 Oct;50(2):597-612. doi: 10.1007/s12035-014-8684-y. Epub 2014 Apr 3. Review.

PMID:
24696267
13.

[Current studies on induced pluripotent stem cells in retinal degenerative diseases].

Zhu JL, Zheng QX, Li WS.

Zhonghua Yan Ke Za Zhi. 2012 Apr;48(4):374-8. Review. Chinese.

PMID:
22800459
15.

iPS cells in type 1 diabetes research and treatment.

Maehr R.

Clin Pharmacol Ther. 2011 May;89(5):750-3. doi: 10.1038/clpt.2011.1. Epub 2011 Mar 23. Review. No abstract available.

PMID:
21430661
16.

[Clinical application strategy by iPS cells].

Eto K.

Rinsho Ketsueki. 2013 Oct;54(10):1554-8. Review. Japanese. No abstract available.

PMID:
24064803
17.

Epigenetic rejuvenation.

Manukyan M, Singh PB.

Genes Cells. 2012 May;17(5):337-43. doi: 10.1111/j.1365-2443.2012.01595.x. Epub 2012 Apr 4. Review.

18.

General Spinfection Protocol.

Berggren WT, Lutz M, Modesto V.

StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-.
2012 Dec 10.

Supplemental Content

Support Center